Kite’s CAR T-cell Therapy Yescarta Granted European Marketing Authorization for the Treatment of Relapsed or Refractory Follicular Lymphoma Read more
Japan’s Ministry of Health, Labour and Welfare accepts Shingrix regulatory submission to prevent shingles in at-risk adults aged 18 years and older Read more
Terumo Blood and Cell Technologies and GenCure collaborate to advance cell and gene therapy manufacturing solutions Read more
Novartis Tafinlar + Mekinist receives FDA approval for first tumor-agnostic indication for BRAF V600E solid tumors Read more
Novartis receives European Commission approval for Tabrecta for the treatment of METex14 skipping advanced non-small cell lung cancer Read more
Radius Health Announces Agreement to be Acquired by Gurnet Point Capital and Patient Square Capital Read more
Novavax’ Nuvaxovid COVID-19 Vaccine Receives Emergency Use Authorization in Taiwan for Use in Individuals Aged 18 and Over Read more
Ellipses Announces FDA Clearance of IND Application for EP0031 for Patients With Advanced RET-altered Malignancies Read more